8.93
price down icon1.54%   -0.14
pre-market  시장 영업 전:  9.04   0.11   +1.23%
loading

Alvotech 주식(ALVO)의 최신 뉴스

pulisher
Jun 19, 2025

Day 8 of Loss Streak for Alvotech Stock with -15% Return (vs. -32% YTD) [6/18/2025] - Trefis

Jun 19, 2025
pulisher
Jun 18, 2025

Alvotech and Dr. Reddy’s Partner to Develop Biosimilar of Merck’s Keytruda for Global Cancer Treatment - geneonline.com

Jun 18, 2025
pulisher
Jun 18, 2025

Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Cancer Drug Pembrolizumab - geneonline.com

Jun 18, 2025
pulisher
Jun 17, 2025

Short Interest in Alvotech (NASDAQ:ALVO) Grows By 75.2% - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan - Center for Biosimilars

Jun 17, 2025
pulisher
Jun 17, 2025

Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Keytruda Cancer Drug - geneonline.com

Jun 17, 2025
pulisher
Jun 17, 2025

Alvotech, Dr. Reddy’s to co-develop Keytruda biosimilar - Drug Store News

Jun 17, 2025
pulisher
Jun 16, 2025

Alvotech (NASDAQ:ALVO) Trading Down 3.3%Should You Sell? - MarketBeat

Jun 16, 2025
pulisher
Jun 15, 2025

Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda Biosimilar - MSN

Jun 15, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Trims Position in Alvotech (NASDAQ:ALVO) - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Alvotech and Dr. Reddy’s partner to co-develop biosimilar candidate for Merck's Keytruda - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Linklaters Advises Syndicate on Alvotech’s SEK 750 Million Private Placement - Global Legal Chronicle

Jun 12, 2025
pulisher
Jun 12, 2025

Alvotech Completes Private Placement to Boost Shareholder Base - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Pembrolizumab Used in Cancer Treatment - geneonline.com

Jun 12, 2025
pulisher
Jun 11, 2025

Alvotech completes private placement with 40 institutional investors By Investing.com - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Investors - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech Completes Successful Private Placement with Global Institutional Investors - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

REG-Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors - TradingView

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech Attracts 40 New Global Investors in Strategic Private Placement, 80% First-Time Buyers - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech at Goldman Sachs Conference: Strategic Growth in Biosimilars - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech at Goldman Sachs Conference: Strategic Growth in Biosimilars By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Transcript : Alvotech Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08 - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Alvotech Partners with Dr. Reddy’s for Keytruda Biosimilar Development - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a Bet - MSN

Jun 10, 2025
pulisher
Jun 09, 2025

Alvotech, Advanz Pharma expand biosimilar deal in Europe - Drug Store News

Jun 09, 2025
pulisher
Jun 08, 2025

Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment - MSN

Jun 08, 2025
pulisher
Jun 08, 2025

Dr Reddy’s–Alvotech deal: Why investors are bullish - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Dr Reddys Lab gains on global biosimilar deal with Alvotech - MSN

Jun 07, 2025
pulisher
Jun 07, 2025

Alvotech (NASDAQ:ALVO) Stock Price Down 4.8%What's Next? - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Alvotech and Dr. Reddy’s to co-develop biosimilar candidate to Keytruda® (pembrolizumab) - BioSpectrum Asia

Jun 07, 2025
pulisher
Jun 07, 2025

Alvotech and Dr. Reddy’s Join Forces to Develop Biosimilar | - Chemical Industry Digest

Jun 07, 2025
pulisher
Jun 07, 2025

Alvotech (ALVO) Partners with Dr. Reddy's for Keytruda Biosimila - GuruFocus

Jun 07, 2025
pulisher
Jun 07, 2025

Dr Reddy's, Alvotech join hands to co-develop, manufacture & commercialise biosimilar of Merck's blockbuster drug Keytruda - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

Alvotech and Dr. Reddy’s partner for Keytruda biosimilar - Pharmaceutical Business review -

Jun 06, 2025
pulisher
Jun 06, 2025

Dr Reddy's, Alvotech Partner To Develop Biosimilar For Cancer Treatment - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Alvotech and Dr. Reddy’s to co-develop biosimilar to Keytruda - World Pharmaceutical Frontiers

Jun 06, 2025
pulisher
Jun 06, 2025

Dr Reddy’s shares climb over 4% after Keytruda biosimilar deal with Alvotech - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Alvotech to Participate in Goldman Sachs 46th Global Healthcare Conference in Miami - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami - Yahoo

Jun 06, 2025
pulisher
Jun 05, 2025

Alvotech (ALVO) Trading Down 4.8% on Jun 4 - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Alvotech Completes SEK 750 Million Private Placement to Boost R&D and Market Position - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug - Benzinga

Jun 05, 2025
$14.72
price up icon 2.01%
$9.34
price up icon 1.74%
$129.40
price up icon 1.09%
$295.22
price up icon 1.48%
drug_manufacturers_specialty_generic RDY
$14.88
price down icon 0.40%
$17.05
price up icon 2.46%
자본화:     |  볼륨(24시간):